Mattison DR - Search Results

1

Completeness of serious adverse drug event reports received by the US Food and Drug Administration in 2014.

Moore TJ, Furberg CD, Mattison DR, Cohen MR. Moore TJ, et al. Among authors: mattison dr. Pharmacoepidemiol Drug Saf. 2016 Jun;25(6):713-8. doi: 10.1002/pds.3979. Epub 2016 Feb 10. Pharmacoepidemiol Drug Saf. 2016. PMID: 26861066

2

Dabigatran, bleeding, and the regulators.

Moore TJ, Cohen MR, Mattison DR. Moore TJ, et al. Among authors: mattison dr. BMJ. 2014 Jul 23;349:g4517. doi: 10.1136/bmj.g4517. BMJ. 2014. PMID: 25056265 No abstract available.

3

Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs.

Moore TJ, Glenmullen J, Mattison DR. Moore TJ, et al. Among authors: mattison dr. JAMA Intern Med. 2014 Dec;174(12):1930-3. doi: 10.1001/jamainternmed.2014.5262. JAMA Intern Med. 2014. PMID: 25329919

4

Patterns and prevalence of medication use across the menstrual cycle among healthy, reproductive aged women.

Johnson KA, Sjaarda LA, Mumford SL, Garbose RA, Schliep KC, Mattison D, Perkins NJ, Wactawski-Wende J, Schisterman EF. Johnson KA, et al. Pharmacoepidemiol Drug Saf. 2016 Jun;25(6):618-27. doi: 10.1002/pds.3993. Epub 2016 Mar 8. Pharmacoepidemiol Drug Saf. 2016. PMID: 26954695 Free PMC article.

5

Adult Utilization of Psychiatric Drugs and Differences by Sex, Age, and Race.

Moore TJ, Mattison DR. Moore TJ, et al. Among authors: mattison dr. JAMA Intern Med. 2017 Feb 1;177(2):274-275. doi: 10.1001/jamainternmed.2016.7507. JAMA Intern Med. 2017. PMID: 27942726 No abstract available.

6

Assessment of Patterns of Potentially Unsafe Use of Zolpidem.

Moore TJ, Mattison DR. Moore TJ, et al. Among authors: mattison dr. JAMA Intern Med. 2018 Sep 1;178(9):1275-1277. doi: 10.1001/jamainternmed.2018.3031. JAMA Intern Med. 2018. PMID: 30014137 Free PMC article.

7

Systemic quinolones and risk of retinal detachment I: analysis of data from the US FDA adverse event reporting system.

Taher MK, Alami A, Gravel CA, Tsui D, Bjerre LM, Momoli F, Mattison D, Krewski D. Taher MK, et al. Expert Opin Drug Saf. 2022 Feb;21(2):269-276. doi: 10.1080/14740338.2022.1993187. Epub 2021 Oct 24. Expert Opin Drug Saf. 2022. PMID: 34641748

8

Safety and effectiveness of NMDA receptor antagonists for depression: A multidisciplinary review.

Moore TJ, Alami A, Alexander GC, Mattison DR. Moore TJ, et al. Among authors: mattison dr. Pharmacotherapy. 2022 Jul;42(7):567-579. doi: 10.1002/phar.2707. Epub 2022 Jun 26. Pharmacotherapy. 2022. PMID: 35665948 Free PMC article. Review.

9

A tale of two citizens: a State Attorney General and a hematologist facilitate translation of research into US Food and Drug Administration actions--a SONAR report.

Chen B, Restaino J, Norris L, Xirasagar S, Qureshi ZP, McKoy JM, Lopez IS, Trenery A, Murday A, Kahn A, Mattison DR, Ray P, Sartor O, Bennett CL. Chen B, et al. Among authors: mattison dr. J Oncol Pract. 2012 Nov;8(6):e158-67. doi: 10.1200/JOP.2011.000504. Epub 2012 Aug 14. J Oncol Pract. 2012. PMID: 23598851 Free PMC article.

10

Systematic review and meta-analysis of adverse cardiovascular events associated with proton pump inhibitors used alone or in combination with antiplatelet agents.

Farhat N, Fortin Y, Haddad N, Birkett N, Mattison DR, Momoli F, Wu Wen S, Krewski D. Farhat N, et al. Among authors: mattison dr. Crit Rev Toxicol. 2019 Mar;49(3):215-261. doi: 10.1080/10408444.2019.1583167. Epub 2019 Jun 13. Crit Rev Toxicol. 2019. PMID: 31192763

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

236 results

Search Page